Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases

Digestive Diseases

Volumn 19, Issue 2, 2001, Pages 104-111

  Ernst, Peter B ^a   Takaishi, Hiromasa ^a   Crowe, Sheila E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bacteria; Cytokines; Immunity; Immunopathogenesis; Inflammatory bowel disease; T cells; Vaccines

Indexed keywords

ATROPHIC GASTRITIS; B LYMPHOCYTE; CELIAC DISEASE; CHRONIC INFLAMMATION; DISEASE MODEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MACROPHAGE; NEUTROPHIL; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; T LYMPHOCYTE;

CHRONIC DISEASE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES;

EID: 0034847297     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050663     Document Type: Review

References (87)

1. Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice
2. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: Effects of flora and proinflammatory cytokines
3. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta-2 microglobulin transgenic rats
4. A frame-shift mutation in NOD2 associated with susceptibility to Crohn's disease
5. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
6. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
7. Interleukin-10 promoter haplotype is associated with increased risk for gastric cancer during Helicobacter pylori infection
8. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model
9. Helicobacter pylori virulence and genetic geography
10. Helicobacter pylorifactors associated with disease
11. The disease spectrum of H. pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer
12. Pathogenic mechanisms of Helicobacter pylori
13. Pathophysiology of Helicobacter pylori infection
14. Helicobacter pylori and gastric carcinogenesis
15. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease
16. Expression of interleukin-8 and CD54 by human gastric epithelium after H. pylori infection in vitro
17. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes
18. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis
19. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappa B-like binding sites of the interleukin 8 gene
20. Biology of disease: Cell and tissue responses to oxidative damage
21. Possibility of chemoprevention by the eradication of Helicobacter pylori: Oxidative DNA damage and apoptosis in H. pylori infection
22. Oxidant-induced activation of nuclear factor-kappa B in cultured guinea pig gastric epithelial cells
23. Oxidative DNA damage accumulation in gastric carcinogenesis
24. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide
25. Helicobacter pylori causes DNA damage in gastric epithelial cells
26. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury
27. Determinants of Helicobacter pylori infection and chronic gastritis
28. Bugs on trial: The case of Helicobacter pylori and autoimmunity
29. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
30. Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease
31. Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: Relation to chronic gastritis and glandular atrophy
32. Bacteroides gingivalis-specific serum IgG and IgA subclass antibodies in periodontal diseases
33. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease
34. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease
35. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis
36. Complement activation directly induced by Helicobacter pylori
37. The human gastrointestinal secretory immune system in health and disease
38. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis
39. Chemokines in the gastric mucosa in Helicobacter pylori infection
40. Induction of IL-12 and selection of Th1 cells in the gastric mucosa in response to H. pylori
41. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: Relation to bacterial cag status and peptic ulceration
42. Expression of interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection
43. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
44. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis
45. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
46. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
47. Local cytokine response in Helicobacter pylori-infected subjects
48. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection
49. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques
50. Is the Th1/Th2 lymphocyte balance upset by H. pylori infection?
51. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice
52. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori
53. Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by Helicobacter pylori-infected gastric mucosal epithelium: Human glandular stomach as a site of immune privilege
54. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions
55. Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines
56. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway
57. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression
58. Tumor necrosis factor alpha and interleukin 1 beta upregulate gastric mucosal Fas antigen expression in Helicobacter pylori infection
59. Regulation of epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis
60. The effect of class II MHC expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: A mechanism for Th1 cell-mediated damage
61. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
62. Protection of germ-free mice from infection by Helicobacter felis-induced inflammation
63. Protection by human milk IgA against Helicobacter pylori infection in infancy
64. Preventive and therapeutic vaccines against Helicobacter pylori: Current status and future challenges
65. Rational design of vaccines
66. Vaccine strategies for prevention of Helicobacter pylori infections
67. Helicobacter pylori vaccines - The current status
68. Oral immunization against Helicobacter pylori
69. Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model
70. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: Evidence of protection in a mouse model of gastric infection
71. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease
72. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis
73. Mutants of Escherichia coli heat labile toxin lacking ADP-ribosyltransferase activity act as non-toxic, mucosal adjuvants
74. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
75. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice
76. Therapeutic immunization against Helicobacter mustale in naturally infected ferrets
77. Therapeutic immunization against Helicobacter pylori infection
78. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
79. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
80. Helicobacter pylori infections in IgA deficiency: Lack of role for the secretory immune system
81. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice
82. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
83. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice
84. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection
85. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model
86. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy
87. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice